ZA822355B - Oxazole derivatives - Google Patents

Oxazole derivatives

Info

Publication number
ZA822355B
ZA822355B ZA822355A ZA822355A ZA822355B ZA 822355 B ZA822355 B ZA 822355B ZA 822355 A ZA822355 A ZA 822355A ZA 822355 A ZA822355 A ZA 822355A ZA 822355 B ZA822355 B ZA 822355B
Authority
ZA
South Africa
Prior art keywords
oxazole derivatives
oxaprozin
calcium
palatable
preparation
Prior art date
Application number
ZA822355A
Other languages
English (en)
Inventor
Saeed Hughal Ahmed
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of ZA822355B publication Critical patent/ZA822355B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA822355A 1981-04-28 1982-04-05 Oxazole derivatives ZA822355B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8113074 1981-04-28

Publications (1)

Publication Number Publication Date
ZA822355B true ZA822355B (en) 1983-11-30

Family

ID=10521427

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA822355A ZA822355B (en) 1981-04-28 1982-04-05 Oxazole derivatives

Country Status (24)

Country Link
US (2) US4465838A (sh)
EP (1) EP0063884B1 (sh)
JP (1) JPS57181072A (sh)
KR (1) KR880000871B1 (sh)
AT (1) ATE14015T1 (sh)
AU (1) AU544975B2 (sh)
CA (1) CA1169867A (sh)
CS (1) CS236674B2 (sh)
DD (1) DD202017A5 (sh)
DE (1) DE3264400D1 (sh)
DK (1) DK150604C (sh)
ES (1) ES8307230A1 (sh)
FI (1) FI71314C (sh)
GR (1) GR75913B (sh)
HU (1) HU185276B (sh)
IE (1) IE52909B1 (sh)
IL (1) IL65443A (sh)
MY (1) MY8700599A (sh)
NZ (1) NZ200247A (sh)
PH (1) PH18053A (sh)
PL (1) PL136322B1 (sh)
PT (1) PT74794B (sh)
ZA (1) ZA822355B (sh)
ZW (1) ZW7482A1 (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US6726928B2 (en) * 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
DE69733752T2 (de) * 1996-05-20 2006-06-01 G.D. Searle Llc, Chicago Arzneimittel enthaltend oxaprozin-natriumsalz,-kaliumsalz, oder-tris(hydroxymethyl)aminomethansalz
US7358254B2 (en) * 2001-07-13 2008-04-15 Bristol-Myers Squibb Company Method for treating atherosclerosis employing an aP2 inhibitor and combination
AU2006228869A1 (en) * 2005-03-30 2006-10-05 Astion Pharma A/S Oxaprozin or a closely related compound for the treatment of eczema
US20060229347A1 (en) * 2005-03-30 2006-10-12 Astion Development A/S Treatment of eczemas
CN102197163B (zh) * 2008-08-26 2014-03-05 多尔夫凯塔尔化学制品（I）私人有限公司 一种用于抑制酸腐蚀的新型添加剂及其使用方法
KR20140065862A (ko) * 2012-11-22 2014-05-30 에스케이케미칼주식회사 발포성 속붕해성 이매티닙 제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles

Also Published As

Publication number Publication date
CA1169867A (en) 1984-06-26
DD202017A5 (de) 1983-08-24
HU185276B (en) 1984-12-28
JPS57181072A (en) 1982-11-08
DE3264400D1 (en) 1985-08-01
ZW7482A1 (en) 1983-11-09
CS236674B2 (en) 1985-05-15
PL136322B1 (en) 1986-02-28
IE52909B1 (en) 1988-04-13
GR75913B (sh) 1984-08-02
IL65443A (en) 1985-04-30
FI71314C (fi) 1986-12-19
ATE14015T1 (de) 1985-07-15
NZ200247A (en) 1984-10-19
AU544975B2 (en) 1985-06-27
KR830009772A (ko) 1983-12-23
JPH0261466B2 (sh) 1990-12-20
FI821324A0 (fi) 1982-04-15
IE820766L (en) 1982-10-28
US4465838A (en) 1984-08-14
ES511730A0 (es) 1983-07-01
PT74794A (en) 1982-05-01
PH18053A (en) 1985-03-18
DK150604C (da) 1987-12-07
EP0063884A1 (en) 1982-11-03
PL236145A1 (sh) 1982-12-06
ES8307230A1 (es) 1983-07-01
AU8237882A (en) 1982-11-04
PT74794B (en) 1983-11-07
FI821324L (fi) 1982-10-29
US4532253A (en) 1985-07-30
IL65443A0 (en) 1982-07-30
MY8700599A (en) 1987-12-31
DK150604B (da) 1987-04-13
DK183582A (da) 1982-10-29
FI71314B (fi) 1986-09-09
KR880000871B1 (ko) 1988-05-28
EP0063884B1 (en) 1985-06-26

Similar Documents

Publication Publication Date Title
ZA928554B (en) The use preparations of Curcuma plants.
DE3780223D1 (de) Arzneimittel mit gesteuerter freisetzung.
NL990010I1 (nl) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten.
ES518180A0 (es) Procedimiento para la preparacion de bis-trihidroxibutil-amidas de acidos 2,4,6-triyodoaminoisoftalicos, hidroxietiladas en n.
NZ212067A (en) Derivatives of glycerophosphocholine and glycerophosphoethanolamine; preparation and use
NZ238864A (en) Heterocyclically-substituted oxazole derivatives, preparation and pharmaceutical compositions thereof
DE3264400D1 (en) Oxazole derivatives, their preparation and use
JPS646262A (en) Morpholine derivative, manufacture and medicinal composition
ZA832657B (en) Oxazole derivatives,production and use thereof
IL80290A0 (en) Oxazole and isoxazole derivatives,their manufacture and pharmaceutical compositions containing them
AU6724581A (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
EP0084053A4 (en) Medicines and the use of Sn or Cr protoporphyrin for its manufacture.
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
DE3061614D1 (en) 2,3-dihydro-imidazo (2,1-b) benzothiazole derivatives and pharmaceutical compositions containing them
ES513429A0 (es) "un procedimiento para la preparacion de una composicion nematocida".
SE8204871L (sv) Farmaceutiska preparat, innefattande humant proinsulin
IL65040A (en) Amino-2,1,3-benzothiadiazole and benzoxadiazole derivatives,their preparation and pharmaceutical compositions containing them
DE68907609D1 (de) Arzneimittelzusammensetzung.
DE3260949D1 (en) Benzoyl-phenyl-piperidine derivatives, their preparation and medicinal use
JPS57158761A (en) 4(5)-alkylthioimidazole derivative, manufacture and medicinal composition
IT8820572A0 (it) Agente antitussivo e mucoregolatore, sua preparazione e composizioni farmaceutiche.
IT8520877A0 (it) Procedimento di preparazione di derivati del 9h-xanthen-9-one, derivati cosi' ottenuti e loro impiego terapeutico.
JPS57154184A (en) Amino-2,1,3-benzothiadiazole and benzoxadiazole derivatives, manufacture and pharmaceutical composition containing them